Zeon Corporation reaches agreement for Aurora Microplates acquisition Will Accelerate the Development of Healthcare and Life Sciences Business

Zeon Corporation (President and CEO: Kimiaki Tanaka) has reached an agreement under which its subsidiary will acquire Aurora Microplates (representative: Charles R. Powell, head office: Montana, U.S.A.), a company that sells microplate used in biochemical analysis. As a result of this agreement, Zeon will accelerate business development in healthcare and life sciences, a key area [...]

Phenotypeca announces commencement of ‘Lab 4.0’ Project

This unique consortium will design and build our production platform lab using Robotics, Automation, Artificial Intelligence (AI), and Machine Learning (ML), enabling Phenotypeca to reduce the time and cost to develop their industrial strains of baker’s yeast, meaning that customers can make medicines more affordable to everyone.  Phenotypeca, the leading baker’s yeast biofoundry and generators [...]

IonOpticks enters into OEM partnership with Bruker

IonOpticks enters into OEM partnership with Bruker that sets a new standard for mass spectrometry-based research IonOpticks on track to become the global leader of chromatography for proteomics applications Melbourne – Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation (Nasdaq: BRKR), allowing Bruker to expand their portfolio of 4D-Proteomics [...]

Expanding Market Share in the Pharma/Biopharma Market with New LC Release of the Nexera XS inert High-Performance Liquid Chromatograph

Shimadzu Corporation announces the release of the Nexera XS inert high-performance liquid chromatograph globally. The Nexera XS inert incorporates rust-resistant materials and nonmetallic materials that limit the adsorption of molecules to provide stable measurements such as biopharmaceuticals and medium molecule pharmaceuticals*1. Through this product, Shimadzu aims to expand its business performance in the market for [...]

PerkinElmer to Showcase Expanded Life Science / Cell & Gene Therapy Portfolios and Automated Genomic Workflows at SLAS 2022

End-to-end solutions designed to help scientists streamline and improve drug discovery R&D productivity WHAT:  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 along with several of its new partner companies showcasing how its end-to-end life science solutions and automated workflows can accelerate scientists’ R&D productivity [...]

MRM Proteomics, Inc. and Agilent Technologies, Inc.: A Collaboration for Progress

MONTREAL -- MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced [...]

HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board

TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert Spitale, Ph.D., Associate Director and Associate Dean of Research in the School of Pharmacy and Pharmaceutical Services at the University of California, Irvine (UC Irvine), to the [...]

Impilo and SHS acquire Lowenco

VAMDRUP, Denmark – Impilo and SHS have acquired Lowenco A/S (“Lowenco” or the “Company”) from its founder and owners.  Lowenco was founded 2013 in Vamdrup, Denmark, and develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance market. Following an initial [...]

BGL Announces the Sale of Lowenco to Impilo and SHS

Brown Gibbons Lang & Company (BGL), a leading investment banking and financial advisory firm, is pleased to announce the sale of Lowenco A/S (Lowenco), a leading manufacturer of ultra-low temperature (ULT) storage solutions for the pharma industry, to Impilo and SHS. BGL’s Healthcare & Life Sciences investment banking team initiated the transaction and acted as the exclusive [...]

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to assess the clinical value of comprehensive genomic profiling (CGP) in cancer therapy [...]

Access IBO on Knowledge Center